
PRVA shares are trading at $23.06, positioning them within the upper half of their 52-week range, which spans from a low of $16.47 to a high of $26.0899. This indicates the stock has maintained relative strength over the past year, despite being below its annual peak.
Privia Health Group (PRVA) is exhibiting positive technical momentum, with its last trade at $23.06 positioning it in the upper end of its 52-week range of $16.47 to $26.0899. This price level, approximately 11.6% below its annual high, indicates sustained buyer interest over the past year. The key development is the stock's recent crossing above its 200-day moving average, a classic bullish signal often interpreted by technical analysts as the start of a potential long-term uptrend. The combination of trading near its yearly peak while breaking through a significant long-term technical barrier suggests a strengthening trend that warrants investor attention.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment